Identification of priming factors that determine cardiac lineage of cardiac stem cells
确定心脏干细胞心脏谱系的启动因子的鉴定
基本信息
- 批准号:20249046
- 负责人:
- 金额:$ 31.12万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2010
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Increasing evidence indicates that bone morphogenetic proteins (BMPs) are crucial for cardiac induction, specification, and development. Although signaling of BMPs is tightly regulated through soluble BMP-binding proteins, how they regulate BMP signaling during cardiac differentiation remains unknown. To identify molecules responsible for BMP signaling during early cardiomyocyte differentiation of P19 cells, cDNA subtraction was performed. We found a bimodal expression of the BMP-binding protein Crossveinless-2 (Cv2) during cardiomyocyte differentiation ; Cv2 is temporally expressed earlier than cardiac transcription factors such as Nkx2.5 and Tbx5 and acts as a suppressor for BMP signaling in P19 cells. We established a P19 clonal cell line harboring a cardiac alpha-myosin heavy chain promoter-driven enhanced green fluorescent protein gene to monitor cardiac differentiation by flow cytometry. Treatment with BMP2 during the first 2 days of differentiation suppressed cardiomyocyte differentiation through activation of down-stream targets Smadl/5/8 protein and Idl gene, whereas treatment with Cv2 conversely inhibited Smadl/5/8 activation and Idl expression, leading to increased generation of cardiac cells. RNA interference-mediated knockdown (KD) of endogenous Cv2 showed increased Smadl/5/8 activation and impaired cardiomyocyte differentiation. Expression of cardiac mesoderm markers was reduced, whereas expression of Idl and endoderm markers such as Sox7, Hnf4, and E-cadherin was induced in Cv2-kinase dead cells. These phenotypes were rescued by the addition of Cv2 protein to the culture media during the first 2 days of differentiation or co-culture with parental cells. These data suggest that Cv2 may specify cardiac mesodermal lineage through inhibition of BMP signaling at early stage of cardiogenesis.
越来越多的证据表明,骨形态发生蛋白(BMPs)对心脏的诱导、规范和发育至关重要。尽管BMP的信号通过可溶性BMP结合蛋白受到严格调节,但它们在心脏分化过程中如何调节BMP信号仍然未知。为了鉴定在P19细胞早期心肌细胞分化过程中负责BMP信号传导的分子,我们进行了cDNA减法。我们发现在心肌细胞分化过程中bmp结合蛋白Crossveinless-2 (Cv2)的双峰表达;Cv2的暂时表达早于心脏转录因子如Nkx2.5和Tbx5,并在P19细胞中作为BMP信号的抑制因子。我们建立了一株含有心肌α -肌球蛋白重链启动子驱动的增强型绿色荧光蛋白基因的P19克隆细胞系,通过流式细胞术监测心脏分化。在分化的前2天,BMP2通过激活下游靶点Smadl/5/8蛋白和Idl基因来抑制心肌细胞分化,而Cv2则反过来抑制Smadl/5/8的激活和Idl的表达,导致心肌细胞的生成增加。RNA干扰介导的内源性Cv2敲低(KD)显示Smadl/5/8激活增加和心肌细胞分化受损。心肌中胚层标志物的表达减少,而Idl和内胚层标志物如Sox7、Hnf4和E-cadherin在cv2激酶死亡细胞中被诱导表达。在分化的前2天,将Cv2蛋白添加到培养基中或与亲本细胞共培养,可以挽救这些表型。这些数据表明,Cv2可能通过在心脏发生早期抑制BMP信号来指定心脏中胚层谱系。
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
心筋由来幹細胞移植による世界初の心筋再生療法 CARDLC PRACTICE
全球首个利用心肌干细胞移植的心肌再生疗法CARDLC PRACTICE
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:谷口法正;竹原有史;松原弘明
- 通讯作者:松原弘明
Bone marrow AT1 augments neointima formation by promoting mobilization of smooth muscle progenitors via of Smooth Muscle Progenitors via Platelet-Derived SDF-1{alpha}.
骨髓 AT1 通过血小板衍生的 SDF-1{alpha} 促进平滑肌祖细胞的动员,从而增强新内膜形成。
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Yokoi I;Matsubara H;他8人、最終著者
- 通讯作者:他8人、最終著者
Paracrine Osteogenic Signals via Bone Morphogenetic Protein-2 Accelerate the Atherosclerotic Intimal Calcification In Vivo
- DOI:10.1161/atvbaha.110.206185
- 发表时间:2010-10-01
- 期刊:
- 影响因子:8.7
- 作者:Nakagawa, Yusuke;Ikeda, Koji;Matsubara, Hiroaki
- 通讯作者:Matsubara, Hiroaki
Long-Term Clinical Outcome of Therapeutic Angiogenesis by Autologous Transplantation of Bone Marrow Mononuclear Cells for Patients With Chronic Limb Ischemia-Results of the TACT Trial, Prognosis, Efficacy and Safety
自体骨髓单核细胞移植治疗慢性肢体缺血患者血管生成的长期临床结果 - TACT 试验结果、预后、疗效和安全性
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:的場聖明;他
- 通讯作者:他
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUBARA Hiroaki其他文献
MATSUBARA Hiroaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUBARA Hiroaki', 18)}}的其他基金
A molecular link between metabolic syndrome and energy metabolism in the heart
代谢综合征与心脏能量代谢之间的分子联系
- 批准号:
23659423 - 财政年份:2011
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Cardiac Repair of Severe Heart Failure by Human Heart- or Skeletal Muscle-Derived Multipotent Stem Cells
人类心脏或骨骼肌来源的多能干细胞对严重心力衰竭的心脏修复
- 批准号:
17209028 - 财政年份:2005
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Angiogenic Cell Therapy by Bone Marrow-Derived Monocyte-lineage Stem Cells
骨髓来源的单核细胞谱系干细胞的血管生成细胞疗法
- 批准号:
15390254 - 财政年份:2003
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic angiogenesis by transplantation of bone marrow stem cells
通过骨髓干细胞移植进行治疗性血管生成
- 批准号:
13470152 - 财政年份:2001
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Angiotensin II Type 2 (AT2) Receptor Singnal and Cardiovascular Action
血管紧张素 II 2 型 (AT2) 受体信号和心血管作用
- 批准号:
11470166 - 财政年份:1999
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gene regulation and biophysiological significance of angiotensin type 2 receptor
血管紧张素2型受体的基因调控及其生物生理意义
- 批准号:
09470175 - 财政年份:1997
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular-mechanism for nephrogenic diabetes insipidus
肾性尿崩症的分子机制
- 批准号:
07671164 - 财政年份:1995
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of thyroid hormone response element of atrial natriuretic factor
心房钠尿因子甲状腺激素反应元件的鉴定
- 批准号:
04833025 - 财政年份:1992
- 资助金额:
$ 31.12万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)